Anthrasil
Total Payments
$18,748
Transactions
4
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $9,374 | 2 | 0 |
| 2020 | $9,374 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $18,748 | 4 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| AX003A | Emergent BioSolutions Inc. | $9,374 | 0 |
| AX003B | Emergent BioSolutions Inc. | $9,374 | 0 |
Top Doctors Receiving Payments for Anthrasil
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Omaha, NE | $18,748 | 4 |
Ad
Manufacturing Companies
- Emergent BioSolutions Inc. $18,748
Product Information
- Type Drug
- Total Payments $18,748
- Total Doctors 0
- Transactions 4
About Anthrasil
Anthrasil is a drug associated with $18,748 in payments to 0 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Emergent BioSolutions Inc..
Payment data is available from 2020 to 2021. In 2021, $9,374 was paid across 2 transactions to 0 doctors.
The most common payment nature for Anthrasil is "Unspecified" ($18,748, 100.0% of total).
Anthrasil is associated with 2 research studies, including "AX003A" ($9,374).